What ETHERA HEALTH LTD does

Ethera Health Ltd is a privately held UK digital health company that operates the HALO-X remote patient monitoring platform. Its integrated product stack comprises three components: the HALO-X mobile application for patient-facing health status tracking and validated health survey submission, the MyLoopa Healthband (also referenced as the Ethera Health Band), a waterproof wearable with a 72-hour battery that monitors heart rate, heart rate variability and step count, and a web-based Health Intelligence Platform for clinicians that aggregates biometric and patient-reported outcome data and applies machine learning analytics to flag patients who may need additional support. The platform integrates natively with Apple HealthKit and Google Fit to broaden wearable compatibility, and supports both iOS 11+ and Android 6+ devices.

Ethera has been developed in close collaboration with the CODI Research Group at University College London, led by Professor Ivana Drobnjak (Professor of Computational Healthcare) alongside clinical leadership from Professor John Kelly (Professor of Uro-Oncology) and co-founder Dr Pramit Khetrapal. The platform has been deployed across multiple clinical studies including the iROC Phase III randomised controlled trial (published in JAMA in 2022), DREAMPath Phase II, HALO-S Phase II and HALO-Trak, supporting remote monitoring of post-surgical recovery, chemotherapy side effects and general patient deterioration detection at home.

The commercial model combines a research-driven channel with a consumer subscription channel: free access is provided to academic research teams, clinical trial distribution is invitation-only via participating hospitals and study teams, and broader consumer availability is gated by newsletter signup with paid monthly subscriptions transacted through the Apple App Store and Google Play Store. Ethera is currently constrained to UK-only distribution and has no disclosed funding rounds, revenue figures, or named commercial healthcare customers.

Name

ETHERA HEALTH LTD

Legal name

Ethera Health Ltd

Website

https://ethera.health

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Ethera Health Ltd is a UK digital health company operating the HALO-X remote patient monitoring platform, combining a mobile app, MyLoopa wearable, and clinician analytics for post-surgical, chemotherapy and clinical trial patients in partnership with UCL's CODI Research Group.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Hospital-at-Home & Virtual Ward IoT (HLACAPAC)

akta.pro secondary industries

Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF)

Keywords

• Remote patient monitoring
• Digital health platform
• Wearable health devices
• Health intelligence analytics
• Mobile health applications

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

1. App Subscription: The HALO-X mobile app is free to download, but users must pay applicable subscription fees through the App Store to receive paid services. Payment must be made in advance in cleared funds through the App and relevant App Store.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Ethera Health Ltd operates the HALO-X platform, a cloud-based remote patient monitoring solution combining a consumer mobile app, a wearable healthband (MyLoopa), and a web-based clinician dashboard. The platform collects validated health survey data and continuous biometric sensor data, applies machine-learning analytics, and supports patients recovering at home after surgery or during treatments such as chemotherapy while connecting them with their clinical teams.

Product overview

Ethera Health Ltd offers the HALO-X platform, a comprehensive remote patient monitoring solution designed to support patient care at home. The platform comprises three integrated components: the HALO-X Mobile App (for patients to track health status and submit survey data), the MyLoopa Healthband (a wearable device providing continuous biometric monitoring with a 72-hour battery), and the HALO-X Health Intelligence Web Platform (for clinicians to view data and receive machine learning-powered health analysis). The platform also integrates with Apple HealthKit and Google Fit for extended wearable device compatibility.

Differentiator

Problem solved

Functional benefit

Brands

• HALO-X: Digital health platform connecting patients and clinicians with mobile app, wearable technology (MyLoopa healthband), and web-based health intelligence platform for remote patient monitoring.
• MyLoopa

Products and services

• HALO-X Platform Remote patient monitoring platform that collates data from wearable sensors and validated health surveys to provide high-grade data analysis supporting clinical decision making. Connects patients and clinicians across post-surgical recovery, chemotherapy, and clinical trial use cases.
• HALO-X Mobile App Intuitive patient-facing mobile application allowing users to view their health status, provide validated health survey data, review biometric dashboards, schedule clinical events, and stay connected with their clinical team. Works with the Ethera Health Band, MyLoopa band, or compatible wearables via Apple HealthKit or Google Fit.
• MyLoopa Healthband Comfortable, waterproof wearable device providing accurate biometric sensor monitoring including heart rate, heart rate variability, and step count. Features a 72-hour battery for continuous health monitoring and seamlessly connects to the HALO-X platform.
• HALO-X Health Intelligence Platform Web-based clinician dashboard offering high-grade data analysis, customisable validated questionnaires and PROM surveys, machine-learning-supported health analysis, and treatment recovery progress monitoring to support clinical decision making for doctors and nurses.

Quantifiable outcome

• HALO-S study findings suggest that the MyLoopa device can detect acute deterioration in patients after discharge from hospital following cancer surgery.
• +1 more outcomes

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• CODI Research Group at University College LondoncoreStrategic or Co-development PartnerEthera collaborates closely with the CODI Research Group at UCL to develop innovative predictive health models. The partnership focuses on combining clinical expertise with computational healthcare to improve patient monitoring solutions. Professor John Kelly leads the group which includes Professor Ivana Drobnjak who leads the CODI Research Group. Multiple joint research publications have resulted from this collaboration including studies on remote monitoring following surgery and wearable device applications in healthcare.

Scale indicators2 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Huma (formerly Medopad): London-headquartered digital health platform offering remote patient monitoring for chronic and post-surgical conditions, with hospital partnerships across the NHS — a direct UK competitive peer.
• VitalConnect: Provider of wearable biosensor patches and an RPM platform for continuous vital sign monitoring in hospital and home settings, comparable on hardware-plus-software RPM.
• Vivify Health: End-to-end RPM platform combining mobile apps, BYOD wearable integration, and clinician dashboards for post-discharge and chronic disease management, directly overlapping with HALO-X's stack.
• Biofourmis: AI-driven remote patient monitoring platform combining wearable biosensors with predictive analytics for post-acute and chronic care, closely mirroring HALO-X's hospital-to-home deterioration detection model.
• Current Health: RPM solution pairing a wearable device with a clinician dashboard and AI-based early warning scores for hospital-at-home, paralleling Ethera's MyLoopa + HALO-X + ML deterioration detection.

Emerging players

• Empatica: Medical-grade wearable for continuous biometric monitoring with FDA-cleared AI analytics, an emerging peer in clinical-grade RPM wearables with regulatory approvals Ethera lacks.
• CareBand: Wearable-plus-platform RPM for senior and post-acute populations, a smaller-scale peer with similar IoMT wearable architecture targeting community-based monitoring.
• Withings: Consumer-grade connected health devices (watches, scales, sleep mats) that feed HealthKit/Google Fit, representing the BYOD ecosystem Ethera integrates with and that could be extended into clinical RPM.

Broad incumbents

• Preventice Solutions (Boston Scientific): Established cardiac and ambulatory RPM offering wearable sensors and clinician monitoring as part of a broader medtech portfolio, competing for the same clinician and hospital customers.
• Philips Remote Patient Monitoring: Global medtech incumbent with a deep RPM portfolio across hospital and home, providing direct competition for health system contracts that HALO-X would need to win.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ethera-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ETHERA HEALTH LTD